Literature DB >> 28501117

Institutional variation in surgical care for early-stage breast cancer at community hospitals.

Christopher M Dodgion1, Stuart R Lipsitz2, Marquita R Decker3, Yue-Yung Hu4, Sudha R Pavuluri Quamme3, Anita Karcz5, Leonard D'Avolio6, Caprice C Greenberg7.   

Abstract

BACKGROUND: There is significant institutional variation in the surgical care of breast cancer, and this may reflect access to services and resultant physician practice patterns. In previous studies, specialty care has been associated with variation in the operative treatment of breast cancer but has not been evaluated in a community setting. This study investigates these issues in a cohort of 59 community hospitals in the United States.
MATERIALS AND METHODS: Data on patients receiving an operation for breast cancer (2006-2009) in a large, geographically diverse cohort of hospitals were obtained. Administrative data, autoabstracted cancer-specific variables from free text, and multiple other data sets were combined. Polymotous logistic regression with multilevel outcomes identified associations between these variables and surgical treatment.
RESULTS: At 59 community hospitals, 4766 patients underwent breast conserving surgery (BCS), mastectomy, or mastectomy with reconstruction. The older patients were most likely to receive mastectomy alone, whereas the younger age group underwent more reconstruction (age <50), and BCS was most likely in patients aged 50-65. Surgical procedure also varied according to tumor characteristics. BCS was more likely at smaller hospitals, those with ambulatory surgery centers, and those located in nonmetropolitan areas. The likelihood of reconstruction doubled when there were more reconstructive surgeons in the health services area (P = 0.02). BCS was more likely when radiation oncology services were available within the hospital or network (P = 0.04).
CONCLUSIONS: Interpretation of these results for practice redesign is not straightforward. Although access to specialty care is statistically associated with type of breast surgical procedure, clinical impact is limited. It may be more effective to target other aspects of care to ensure each patient receives treatment consistent with her individual preferences.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28501117      PMCID: PMC5812011          DOI: 10.1016/j.jss.2016.11.065

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  28 in total

1.  Evaluation of a generalizable approach to clinical information retrieval using the automated retrieval console (ARC).

Authors:  Leonard W D'Avolio; Thien M Nguyen; Wildon R Farwell; Yongming Chen; Felicia Fitzmeyer; Owen M Harris; Louis D Fiore
Journal:  J Am Med Inform Assoc       Date:  2010 Jul-Aug       Impact factor: 4.497

2.  A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network.

Authors:  Caprice K Christian; Joyce Niland; Stephen B Edge; Rebecca A Ottesen; Melissa E Hughes; Richard Theriault; John Wilson; Charles A Hergrueter; Jane C Weeks
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Automated concept-level information extraction to reduce the need for custom software and rules development.

Authors:  Leonard W D'Avolio; Thien M Nguyen; Sergey Goryachev; Louis D Fiore
Journal:  J Am Med Inform Assoc       Date:  2011-06-22       Impact factor: 4.497

4.  Implementation of evidence-based psychotherapies for posttraumatic stress disorder in VA specialty clinics.

Authors:  Bradley V Watts; Brian Shiner; Lisa Zubkoff; Elizabeth Carpenter-Song; Julia M Ronconi; Craig M Coldwell
Journal:  Psychiatr Serv       Date:  2014-05-01       Impact factor: 3.084

5.  Automated classification of psychotherapy note text: implications for quality assessment in PTSD care.

Authors:  Brian Shiner; Leonard W D'Avolio; Thien M Nguyen; Maha H Zayed; Bradley V Watts; Louis Fiore
Journal:  J Eval Clin Pract       Date:  2011-02-14       Impact factor: 2.431

6.  Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients.

Authors:  Anneke T Schroen; David R Brenin; Maria D Kelly; William A Knaus; Craig L Slingluff
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

7.  Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction.

Authors:  Amy K Alderman; Sarah T Hawley; Jennifer Waljee; Monica Morrow; Steven J Katz
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

8.  Does it matter where you go for breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for breast cancer.

Authors:  Steven J Katz; Sarah T Hawley; Paul Abrahamse; Monica Morrow; Christopher R Friese; Amy K Alderman; Jennifer J Griggs; Ann S Hamilton; John J Graff; Timothy P Hofer
Journal:  Med Care       Date:  2010-10       Impact factor: 2.983

9.  Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States.

Authors:  Reshma Jagsi; Jing Jiang; Adeyiza O Momoh; Amy Alderman; Sharon H Giordano; Thomas A Buchholz; Steven J Kronowitz; Benjamin D Smith
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

10.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

Authors:  U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

View more
  1 in total

1.  Rural-urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis.

Authors:  Danielle Riley; Elizabeth A Chrischilles; Ingrid M Lizarraga; Mary Charlton; Brian J Smith; Charles F Lynch
Journal:  Cancer Med       Date:  2022-02-11       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.